USA - New York Stock Exchange - NYSE:MED - US58470H1014 - Common Stock
The current stock price of MED is 10.54 USD. In the past month the price decreased by -1.86%. In the past year, price decreased by -40.11%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 63 | 38.14B | ||
| KVUE | KENVUE INC | 16.2 | 33.20B | ||
| ELF | ELF BEAUTY INC | 24.85 | 4.56B | ||
| BRBR | BELLRING BRANDS INC | 12.3 | 3.19B | ||
| COTY | COTY INC-CL A | 16.53 | 2.75B | ||
| IPAR | INTERPARFUMS INC | 16.15 | 2.71B | ||
| OLPX | OLAPLEX HOLDINGS INC | 18.13 | 967.89M | ||
| EPC | EDGEWELL PERSONAL CARE CO | 6.75 | 796.32M | ||
| BNKK | BONK INC | N/A | 482.25M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 7.04 | 473.36M | ||
| NATR | NATURES SUNSHINE PRODS INC | 22.93 | 377.13M | ||
| USNA | USANA HEALTH SCIENCES INC | 10.15 | 363.59M |
Medifast, Inc. is a health and wellness company, which engages in the provision of habit-based and coach-guided lifestyle solutions called OPTAVIA. The company is headquartered in Baltimore, Maryland and currently employs 504 full-time employees. The firm is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. The company sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.
MEDIFAST INC
100 International Drive, 18th Floor
Baltimore MARYLAND 21202 US
CEO: Daniel R. Chard
Employees: 504
Phone: 14105818042
Medifast, Inc. is a health and wellness company, which engages in the provision of habit-based and coach-guided lifestyle solutions called OPTAVIA. The company is headquartered in Baltimore, Maryland and currently employs 504 full-time employees. The firm is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. The company sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.
The current stock price of MED is 10.54 USD.
MEDIFAST INC (MED) has a dividend yield of 9.97%. The yearly dividend amount is currently 0.07.
MED has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
MED stock is listed on the New York Stock Exchange exchange.
The next ex-dividend date for MEDIFAST INC (MED) is September 18, 2023.
MEDIFAST INC (MED) has a market capitalization of 115.83M USD. This makes MED a Micro Cap stock.
ChartMill assigns a fundamental rating of 4 / 10 to MED. While MED has a great health rating, there are worries on its profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.06% | ||
| ROA | 0.09% | ||
| ROE | 0.12% | ||
| Debt/Equity | 0 |
9 analysts have analysed MED and the average price target is 15.3 USD. This implies a price increase of 45.16% is expected in the next year compared to the current price of 10.54.
For the next year, analysts expect an EPS growth of -78.11% and a revenue growth -36.56% for MED